[ad_1]
India
oi-Deepika S
New Delhi, Jan 04: Bharat Biotech, which has been accorded Emergency Use Authorisation from the drug regulator for its COVID-19 vaccine Covaxin, on Monday stated they’re establishing 4 vaccine manufacturing amenities with a mixed capability of 700 million doses each year.
Denying allegations that the city-based vaccine maker lacks information of Covaxin, Krishna Ella, chairman of Bharat Biotech, stated adequate information has already been revealed and is accessible on the web.
“We have four facilities coming up. We are planning around 200 million doses (per annum) in Hyderabad, 500 million doses in other cities. By 2021 we will have 7,600 million doses capacity… as we speak we have 20 million doses, he told reporters.
He said Covaxin is currently undergoing phase 3 clinical trials with 24,000 volunteers.
Covaxin: Meet Tamil farmer’s son who kickstarted Bharat Biotech, developed vaccines against Zika, Chikunguya
“I believe we’re the one firm I can categorically say has acquired in depth analysis expertise and in depth publication peer reviewed journals. Many folks say that I’m not clear in my information. I believe folks ought to have the persistence to learn web and take a look at what our articles are,” he said on the allegations of data availability.
He said Indian companies are being targeted as inferior ones and said his companys work is no less than Pfizer, which also came out with a vaccine for coronavirus.
“Don’t accuse us of inexperience. We are a world firm… have manufactured 16 vaccines. It just isn’t right to say we’re not clear with information. We conduct scientific trials in lots of international locations, together with the UK. The level is we’re not an Indian firm… however a world one,” Dr Ella said.
“We have printed in lots of journals. We have been the primary to establish the Zika virus and the primary to file a world patent for the Zika vaccine and the Chikungunya vaccine. It just isn’t right to say that we’re not clear with information… we do not deserve the backlash,” he added.
He also said the company had “the one BSL-3 (bio-safety degree 3) manufacturing facility on this planet”.
Ella said his company had carried out “200 per cent trustworthy scientific trials”.
“Give me one week”s time, I will provide you with confirmed information,” he said.
Bharat Biotech has manufactured 16 vaccines, he pointed out.
“We usually are not simply an Indian firm, we’re actually a world firm. People mustn’t accuse us that we don”t know scientific analysis…,” he said.
[ad_2]
Source link
